FMR1 and fragile X syndrome: A number of recent findings in Fmr1-knockout mice have shown that the use of mGluR5 inhibitors, such as 2-methyl-6-(phenylethynyl)-pyridine (MPEP), rescues FXS phenotypes [52,53].